SCHEMBL2472947

SCHEMBL2472947

OCCc1cncs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7626178 0.98
Sulfuric Acid SCHEMBL27769600 0.90 SLC6A3 (0.37)
Nitric Acid SCHEMBL27790988 0.87 SLC6A3 (0.36)
Nitric Acid SCHEMBL27769569 0.87 SLC6A3 (0.36)
SCHEMBL2093337 0.86
SCHEMBL5087896 0.85 TBXAS1 (0.37)
SCHEMBL2095928 0.83 TBXAS1 (0.39)
SCHEMBL358882 0.76
SCHEMBL10863918 0.76
SCHEMBL5899126 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336966-B2 Fragrance compositions and uses thereof THE PROCTER & GAMBLE COMPANY (US) 2019-07-02 US claimed
US-9814661-B2 Fragrance compositions THE PROCTER & GAMBLE COMPANY (US) 2017-11-14 US claimed
EP-2961374-B1 FRAGRANCE COMPOSITIONS PROCTER & GAMBLE (US) 2017-01-25 EP claimed
EP-2961374-A1 FRAGRANCE COMPOSITIONS The Procter & Gamble Company (US) 2016-01-06 EP claimed
US-9139567-B2 Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-09-22 US claimed
US-20150164764-A1 Fragrance Compositions THE PROCTER & GAMBLE COMPANY 2015-06-18 US claimed
WO-2015089246-A1 FRAGRANCE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2015-06-18 WO claimed
US-20140221373-A1 ARYLPYRAZOLE ETHERS AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-07 US claimed
EP-2734516-A1 ARYLPYRAZOLE ETHERS AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE Boehringer Ingelheim International GmbH (DE) 2014-05-28 EP claimed
WO-2013012844-A1 ARYLPYRAZOLE ETHERS AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-24 WO claimed
US-20110269748-A1 2-ANILINE-4-ARYL SUBSTITUTED THIAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2011-11-03 US claimed
EP-1926719-A2 2-ANILINE-4-ARYL SUBSTITUTED THIAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2008-06-04 EP claimed
WO-2007031440-A2 2-ANILINE-4-ARYL SUBSTITUTED THIAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2007-03-22 WO claimed
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP claimed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US claimed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP claimed
JP-60045566-A None JP disclosed
US-12508218-B2 Coating compositions COTY INC. (US) 2025-12-30 US disclosed
JP-S6045566-A THIAZOLE DERIVATIVE DAI ICHI SEIYAKU CO LTD 1985-03-12 JP disclosed
EP-0000478-B1 PROCESS FOR THE PREPARATION OF ACYLOINS Henkel Kommanditgesellschaft auf Aktien (DE) 1981-11-25 EP disclosed